Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation.
Knechtle, S J
Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation. [electronic resource] - Surgery Oct 1996 - 719-24 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article
0039-6060
10.1016/s0039-6060(96)80022-5 doi
Adult
Age Factors
Antilymphocyte Serum--therapeutic use
Cadaver
Cohort Studies
Cyclosporine--therapeutic use
Demography
Evaluation Studies as Topic
Female
Graft Rejection--prevention & control
Graft Survival--drug effects
Histocompatibility Testing
Humans
Immunosuppressive Agents--therapeutic use
Kidney Transplantation
Male
Middle Aged
Muromonab-CD3--therapeutic use
Mycophenolic Acid--analogs & derivatives
Tissue Donors
Transplantation, Homologous
Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation. [electronic resource] - Surgery Oct 1996 - 719-24 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article
0039-6060
10.1016/s0039-6060(96)80022-5 doi
Adult
Age Factors
Antilymphocyte Serum--therapeutic use
Cadaver
Cohort Studies
Cyclosporine--therapeutic use
Demography
Evaluation Studies as Topic
Female
Graft Rejection--prevention & control
Graft Survival--drug effects
Histocompatibility Testing
Humans
Immunosuppressive Agents--therapeutic use
Kidney Transplantation
Male
Middle Aged
Muromonab-CD3--therapeutic use
Mycophenolic Acid--analogs & derivatives
Tissue Donors
Transplantation, Homologous